STOCK TITAN

Masimo Corp - MASI STOCK NEWS

Welcome to our dedicated news page for Masimo (Ticker: MASI), a resource for investors and traders seeking the latest updates and insights on Masimo.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Masimo's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Masimo's position in the market.

Rhea-AI Summary
Masimo Corporation (Nasdaq: MASI) announced its financial results for the second quarter of 2023. Consolidated revenue was $455.3 million, with healthcare revenue at $281.1 million and non-healthcare revenue at $174.2 million. GAAP net income per diluted share was $0.29, while non-GAAP net income per diluted share was $0.62. Despite a decline in healthcare revenues and earnings, Masimo gained new hospital customers at a record level and retained existing ones. The updated guidance reflects lower inpatient volumes and the expectation of not receiving some new large orders for their products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.7%
Tags
-
Rhea-AI Summary
Masimo (NASDAQ: MASI) announced that a study found Masimo SedLine® brain function monitoring effectively assesses sedation levels of patients undergoing drug-induced sleep endoscopy with dexmedetomidine, indicating potential to improve monitoring of dexmedetomidine sedation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.52%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
none
-
Rhea-AI Summary
Hospital La Fe in Valencia, Spain, is expanding its telehealth and telemonitoring program with the Masimo W1 advanced health tracking watch. The watch offers accurate, continuous measurements of key physiological parameters and integrates with the Masimo SafetyNet remote patient management and telehealth platform. The hospital plans to equip patients scheduled for elective surgery with the watch to improve prehabilitation through analysis of heart rate variability data.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.78%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.78%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.35%
Tags
none
Masimo Corp

Nasdaq:MASI

MASI Rankings

MASI Stock Data

7.30B
44.60M
7.71%
96.37%
7.99%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
US
Irvine

About MASI

masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.